Mariusz G.
- Country
- Poland
- Department
- Klinika Perinatologii Położnictwa i Ginekologii
Research Overview
- A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN).
- Randomized, Open-Label Study of Nipocalimab Versus Human Normal Immunoglobulin (IV) in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Data & Insights
Has run more than one trial at 8 of 27 partner sites.
Specializations
Maternal-Fetal Medicine
The investigator specializes in the management of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), focusing on innovative therapeutic approaches during pregnancy.
- Pregnancy Complications
- Fetal Medicine
- Neonatal Care
Research activities center on preventive strategies and treatment interventions for maternal-fetal blood disorders.
Hematology
Expertise in platelet disorders and alloimmune conditions affecting pregnancy outcomes, with particular attention to immunological aspects of maternal-fetal medicine.
- Platelet Immunology
- Blood Disorders in Pregnancy
- Immune-Mediated Conditions
Clinical focus includes evaluation of novel therapeutic agents for pregnancy-related blood disorders.
Perinatal Medicine
Dedicated to advancing treatment options for high-risk pregnancies and improving outcomes in cases of maternal-fetal incompatibility.
- Prenatal Diagnosis
- Pregnancy Monitoring
- Fetal Therapy
Investigates therapeutic interventions aimed at preventing adverse pregnancy outcomes related to immune disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.